Atlas Trials

Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I

Clinical trial NCT03071341 · COMPLETED

Trial details

NCT number
NCT03071341
Sponsor
ArmaGen, Inc
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Mucopolysaccharidosis I
Start date
2016-10-01
Primary completion
2018-02-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.